US Executive Officer Management Changes SEC — February 16, 2026

17-02-2026

MaxLinear, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, appointment or resignation, reasons, or quantitative impacts are disclosed.

• ·Event date: February 17, 2026
• ·Filing accession number: 0001288469-26-000017
• ·File size: 210 KB

17-02-2026

Sana Biotechnology, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or timing are explicitly stated. No quantitative data, performance metrics, or further governance implications are mentioned in the provided filing information.

• ·Accession Number: 0001193125-26-053294
• ·Filing size: 346 KB
• ·Event date aligns with filing date (2026-02-17), suggesting prompt disclosure within SEC 4-business-day requirement

17-02-2026

Match Group, Inc. filed an 8-K on February 17, 2026 (AccNo: 0000891103-26-000022, Size: 162 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

MGP Ingredients Inc filed an 8-K on February 17, 2026 (AccNo: 0000835011-26-000006), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for changes, or any quantitative impacts are NOT_DISCLOSED. No positive or negative metrics, financial data, or further context provided.

17-02-2026

LOUISIANA-PACIFIC CORP filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. This appears to be a routine leadership disclosure with no quantified positive or negative impacts provided.

17-02-2026

JFB Construction Holdings filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006871), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics are disclosed. Sector information is not specified.

• ·Filing date: 2026-02-17
• ·Accession Number: 0001493152-26-006871
• ·File size: 208 KB
• ·Event type: Officer Change

17-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals involved, appointment or resignation status, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned in the provided filing information.

17-02-2026

WESCO INTERNATIONAL INC filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. This appears to be a routine governance disclosure with no quantified impacts mentioned.

17-02-2026

Trinity Industries Inc filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or impacts are disclosed.

17-02-2026

Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

17-02-2026

Kyndryl Holdings, Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected (e.g., CEO, CFO), names, reasons for changes, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or scheduled events are mentioned.

17-02-2026

Columbia Financial, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or impacts are provided in the available information. This is a required SEC disclosure for material leadership events, but lacks quantitative or qualitative context.

17-02-2026

Cognex Corp filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists financial statements and exhibits. Specific details including key position affected, appointment or resignation status, reasons for change, timing, names, and any quantitative data are NOT_DISCLOSED.

17-02-2026

Gemini Space Station, Inc. filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential compensatory arrangements, under Item 5.02. No specific details such as the key position affected, appointment or resignation status, reasons for the change, board impacts, financial metrics, or quantitative data are provided. The filing is informational with no disclosed positive or negative performance indicators.

17-02-2026

Cingulate Inc. filed an 8-K on 2026-02-17 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details including affected positions, names, appointment or resignation status, reasons, and any financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events were mentioned.

17-02-2026

Graham Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053140), reporting under Item 5.02 on departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 7.01 on Regulation FD disclosure; and Item 9.01 on financial statements and exhibits. Specific details including officer names, positions, reasons for change, timing, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

CNS Pharmaceuticals, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001683168-26-001066), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial data, or performance comparisons are provided.

17-02-2026

Bowman Consulting Group Ltd. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed. This appears to be a routine governance disclosure without additional performance data.

17-02-2026

CPI Card Group Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-015886, Size: 140 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or financial implications are explicitly stated in the provided filing summary. No quantitative metrics, performance comparisons, or other events are mentioned.

• ·Event date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

Royal Caribbean Cruises Ltd filed a Form 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, reason for change, timing, or any quantitative metrics are provided.

17-02-2026

Earth Science Tech, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

17-02-2026

Lakeland Industries Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053267), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reason for change, or any quantitative impacts are disclosed. Sector is not specified, and no positive or negative metrics are mentioned.

17-02-2026

VirTra, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006967), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals, appointment/resignation status, reasons, timing, or governance implications were provided. No quantitative data, financial metrics, or scheduled events were mentioned.

17-02-2026

MDWerks, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including names, positions, reasons for changes, timing, or any quantitative data are NOT_DISCLOSED.

17-02-2026

NATIONAL HEALTHCARE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons for change, timing, or any quantitative impacts were provided. No positive or negative metrics, governance implications, or board outcomes were mentioned.

17-02-2026

The company filed an 8-K on February 17, 2026 (AccNo: 0001213900-26-017065) disclosing an officer change or compensatory arrangements of certain officers under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. Specific details on the affected officer's name, title (e.g., CEO, CFO), action (appointment, resignation, retirement), reason, timing, or any related compensation are NOT_DISCLOSED. No quantitative data, financial metrics, performance comparisons, scheduled events, or governance impacts are mentioned in the provided filing information.

17-02-2026

SOUTHERN CO filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, internal/external status, or timing are disclosed. No quantitative data, financial metrics, or other impacts are mentioned.

17-02-2026

17-02-2026

Goosehead Insurance, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, timing, and any financial metrics are NOT_DISCLOSED.

17-02-2026

Boston Beer Co Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054573), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative data, financial metrics, or other changes are mentioned.

17-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001193125-26-054550) disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, effective dates, or quantitative impacts are disclosed.

• ·Filing size: 237 KB
• ·Sector: not specified

17-02-2026

Akamai Technologies Inc filed an 8-K on 2026-02-17 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments of certain officers or directors, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for change, or quantitative details provided.

• ·Sector: not specified
• ·Filing Accession Number: 0001086222-26-000004
• ·File Size: 231 KB

17-02-2026

Travelers Companies, Inc. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

17-02-2026

Annexon, Inc. filed a Form 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names of individuals, positions affected, reasons for change, timing, or any quantitative compensation data are provided in the filing summary. This is a standard governance disclosure with no additional financial or operational metrics mentioned.

17-02-2026

Quad/Graphics, Inc. filed an 8-K on 2026-02-17 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed in the provided filing summary.

17-02-2026

ImageneBio, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054684), disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, effective dates, or financial details such as compensation amounts are disclosed in the provided information. No quantitative metrics, performance comparisons, or additional context provided.

17-02-2026

Skillz Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are provided in the filing summary. This appears to be an informational disclosure with no financial metrics or performance comparisons mentioned.

17-02-2026

AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.

17-02-2026

Rockwell Automation, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054744), disclosing an officer change under Item 5.02 related to departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative terms are disclosed.

17-02-2026

Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.

17-02-2026

NorthWestern Energy Group, Inc. filed a Form 8-K on 2026-02-17 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

17-02-2026

Reborn Coffee, Inc. filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative data such as compensation amounts are disclosed. Sector is not specified.

17-02-2026

Lithium Americas Corp. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative metrics are provided. This appears to be a routine governance disclosure with no financial or performance data mentioned.

17-02-2026

Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

17-02-2026

ARBOR REALTY TRUST INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, or quantitative impacts are disclosed.

17-02-2026

WORLD ACCEPTANCE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, timing, or any financial metrics are disclosed.

17-02-2026

CBL & Associates Properties Inc filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed.

17-02-2026

MarketAxess Holdings Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055003), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names of individuals, reasons for the change, effective dates, or any financial metrics are provided. No quantitative data, performance comparisons, or other material impacts are mentioned.

17-02-2026

Carpenter Technology Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054998, Size: 156 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

17-02-2026

Redwire Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided.

17-02-2026

Dorchester Minerals, L.P. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are provided in the filing summary.

17-02-2026

EXICURE, INC. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. This is an informational governance event with no additional performance or financial data provided.

17-02-2026

AirJoule Technologies Corp. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or terms are disclosed.